Drug Channels Leadership Forum Returns to Miami in March 2026 with Enhanced Agenda

The Drug Channels Leadership Forum (DCLF) is set to return for its second installment on March 16–18, 2026, at the Turnberry Resort & Spa in Miami. The event, which debuted in 2025 to strong attendee feedback, will once again bring together senior leaders from across the pharmaceutical and healthcare industries to discuss critical issues affecting the drug channel ecosystem. Designed as an invite-only gathering, DCLF aims to foster candid dialogue among stakeholders including pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, employers, health systems, physician practices, pharmacies, wholesalers, and policymakers.

Organizers have announced enhancements to the 2026 agenda based on feedback from last year’s attendees. The forum will feature provocative panels led by C-suite executives and open Q&A sessions designed for direct engagement. Unlike traditional industry conferences, DCLF excludes exhibit halls and media presence to maintain a confidential environment focused solely on substantive discussions. In 2025, 92% of attendees expressed interest in returning due to the event’s unique format and networking opportunities. Sponsorship opportunities are available for industry suppliers such as technology firms and consulting companies; attendance for these groups is limited and tied directly to sponsorship levels. Invitations for DCLF 2026 will begin circulating in October 2025.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: April 24, 2025

Related posts:

Auto-Pure 2400 Integrates Liquid Handling and Magnetic Cell Isolation for Latent TB Testing AI Enhances Detection of Child Abuse Cases New Scalable Cell Lysis Method Introduced to Optimize Viral Vector Production for Gene Therapy and Vaccines Tarlatamab Receives FDA Accelerated Approval in 2024 for Improving Survival in Advanced Small Cell Lung Cancer

Author

Mark Chiang